You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Umeå based company Betagenon receives €1,8 million, from EU's sought after Horizon 2020 program, to close the gap to the market for their drug against obesity induced diabetes and associated cardiovascular disease. "An increase in calorie intake combined with an inactive life style has broAlready a subscriber Login You…
NeuroVive Pharmaceutical and Yungjin Pharm Corporation have entered into a global licensing agreement on Yungjin Pharm's compound KL1333 for genetic mitochondrial disorders. The in-licensed project is about to enter Phase I clinical development. KL1333 is a drug intended for treatment of orphaAlready a subscriber Login You have read all your…
The Swedish health tech startup plans to use evidence-based methods and clinical research strategies to develop AI algorithms for healthcare. The company is associated to Uppsala University and plans to initiate the first clinical studies in 2019. AlgoDx's most advanced development project involAlready a subscriber Login You have read all your…
Just before Christmas, the Novo Nordisk Foundation announced that it will establish a new centre, the BioInnovation Institute (BII), which aims to help the most talented researchers and entrepreneurs in developing and maturing research projects to a point at which they can attract capital on market Already a subscriber Login…
